BioSpace News Archive

South Carolina is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in physiology, has joined physIQ as Chief Medical Officer.

ICU Medical Inc., a worldwide leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced its Plum 360 smart infusion system is the first to be recognized as the top-performing Smart Pump EMR-Integrated by KLAS Research, a leading global health care research firm.

Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today announced that its board has appointed a new independent director, Enoch Kariuki, PharmD., who most recently served as the chief financial officer of VelosBio.

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its perspectives on recent progress in the Alzheimer’s field.

To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched the new Vectra ® Cardiovascular Risk assessment that can predict the risk for cardiovascular (CV) events in patients with RA.

Sparsentan achieved statistically significant response on interim proteinuria endpoint compared to irbesartan after 36-weeks of treatment To date in the study, sparsentan has been generally well-tolerated and has shown a safety profile comparable to irbesartan Company to host conference call and webcast today at 8:30 a.m. ET

In collaboration with scientists at the National Institute of Infectious Diseases (NIID) in Tokyo, Japan , MAX BioPharma ( www.maxbiopharma.com ) scientists have identified new substances with antiviral activity against the novel coronavirus, SARS-CoV-2, the virus that caused the ongoing global COVID-19 pandemic

Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies, today announced the appointment of biotechnology pioneer Louis Lange , M.D., Ph.D., to its Board of Directors.

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, today announced it has entered into an exclusive license agreement with Ono Pharmaceutical Co., Ltd., for the development and commercialization of RBN-239